Literature DB >> 10925133

Ultrasound-facilitated transport of silver chloride (AgCl) particles in fish skin.

V Frenkel1, E Kimmel, Y Iger.   

Abstract

Electron-dense nano-particles in aqueous suspension were administered by immersion into the epidermis of fish using ultrasound in the therapeutic range. Enhanced permeability of the tissues to the particles was achieved by acoustic cavitation, which induced a controlled level of necrosis in the outer cell layers, and by non-cavitational exposures, which widened intercellular spaces of non-necrosed tissue in deeper regions of the epidermis. Both particle concentration and penetration depth were quantified using transmission electron microscopy. While cavitation-induced perforation was necessary for particles to penetrate into the tissues, non-cavitational exposures during immersions increased the particle flux towards the skin surface, as well as the diffusion rate of the particles within the epidermis and their depth of penetration. The technique described above may potentially be applied for non-stressful, mass-administration of substances into aquatic animals, as well as the relatively new field of ultrasound-facilitated delivery in moist epithelial tissues in humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10925133     DOI: 10.1016/s0168-3659(00)00264-9

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  13 in total

1.  Intramembrane cavitation as a unifying mechanism for ultrasound-induced bioeffects.

Authors:  Boris Krasovitski; Victor Frenkel; Shy Shoham; Eitan Kimmel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

Review 2.  Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.

Authors:  Natalya Rapoport
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-06-22

Review 3.  Phase-shift, stimuli-responsive drug carriers for targeted delivery.

Authors:  Brian E O'Neill; Natalya Rapoport
Journal:  Ther Deliv       Date:  2011-09

Review 4.  Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends.

Authors:  Baris E Polat; Douglas Hart; Robert Langer; Daniel Blankschtein
Journal:  J Control Release       Date:  2011-01-14       Impact factor: 9.776

5.  Pulsed focused ultrasound lowers interstitial fluid pressure and increases nanoparticle delivery and penetration in head and neck squamous cell carcinoma xenograft tumors.

Authors:  Ali Mohammadabadi; Ruby N Huynh; Aniket S Wadajkar; Rena G Lapidus; Anthony J Kim; Christopher B Raub; Victor Frenkel
Journal:  Phys Med Biol       Date:  2020-06-22       Impact factor: 3.609

6.  Investigations into pulsed high-intensity focused ultrasound-enhanced delivery: preliminary evidence for a novel mechanism.

Authors:  Hilary A Hancock; Lauren H Smith; Julian Cuesta; Amir K Durrani; Mary Angstadt; Mark L Palmeri; Eitan Kimmel; Victor Frenkel
Journal:  Ultrasound Med Biol       Date:  2009-07-17       Impact factor: 2.998

7.  Pulsed high intensity focused ultrasound mediated nanoparticle delivery: mechanisms and efficacy in murine muscle.

Authors:  Brian E O'Neill; Howard Vo; Mary Angstadt; King P C Li; Tim Quinn; Victor Frenkel
Journal:  Ultrasound Med Biol       Date:  2008-12-10       Impact factor: 2.998

8.  Pulsed ultrasound expands the extracellular and perivascular spaces of the brain.

Authors:  David S Hersh; Ben A Nguyen; Jimena G Dancy; Arjun R Adapa; Jeffrey A Winkles; Graeme F Woodworth; Anthony J Kim; Victor Frenkel
Journal:  Brain Res       Date:  2016-06-28       Impact factor: 3.252

9.  Pulsed high-intensity focused ultrasound enhances thrombolysis in an in vitro model.

Authors:  Victor Frenkel; Jay Oberoi; Michael J Stone; Melissa Park; Cheri Deng; Bradford J Wood; Ziv Neeman; McDonald Horne; King C P Li
Journal:  Radiology       Date:  2006-02-21       Impact factor: 11.105

Review 10.  Ultrasound mediated delivery of drugs and genes to solid tumors.

Authors:  Victor Frenkel
Journal:  Adv Drug Deliv Rev       Date:  2008-04-03       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.